Specifically, this genotype significantly increased the hazard for developing cognitive decline 3.2 times in comparison with PD patients with other DRD2 genotypes, and determined poorer performances in episodic memory and attention [110]. The gene discussed is DRD2; the disease is Parkinson disease.